logo-loader

Redx Pharma shares soar 69% as executive chairman increases stake

Published: 12:00 25 Apr 2018 BST

Redx Pharma
In lunchtime trading company’s shares soared 69.2% to 16.5p

Redx Pharma Plc (LON:REDX) shares soared as the company announced that Iain Ross, its executive chairman, has today acquired 150,000 Redx oridinary shares at a price of 11p per share.

The drug developer said following this acquisition, Iain Ross will hold 600,000 ordinary shares in the company, representing 0.47% of the issued share capital.

Yesterday Redx Pharma's shares jumped 48% as the company announced the appointment of AstraZeneca PLC (LON:AZN) Lisa Anson as its new chief executive.

READ: Redx Pharma shares soar 48% after it recruits heavy hitter from drugs major AstraZeneca

In lunchtime trading company’s shares soared 69.2% to 16.5p.

 

Redx Pharma achieves milestone with dosing of first participant in Phase 1...

  Redx Pharma PLC (AIM:REDX) CEO Lisa Anson discusses the enrollment of the first participant in its RXC008 Phase 1 clinical trial in an interview with Proactive's Stephen Gunnion. RXC008 is a 'first-in-class' ROCK inhibitor, designed to be gut-restricted, targeting fibrostenotic Crohn's...

1 month ago